Hopp til hovedinnhold

Interstitiell cystitt

Sist oppdatert: Sist revidert:
Sist revidert av:
Definisjon:
Kalles også smertefull blære-syndrom. Karakteriseres ved blære og underlivssmerter kombinert med urge og hyppig vannlatning både dag og natt, uten funn som kan forklare tilstanden
Forekomst:
Ti ganger flere kvinner enn menn rammes, hyppigst fra 30-40 år. Prevalens anslås 5-500 per 100.000
Symptomer:
Symptomene er svært ofte lik de ved urinveisinfeksjon med lindring av smerte ved vannlating
Funn:
Typisk foreligger normale funn
Diagnostikk:
Urindyrkninger er negative
Behandling:
God informasjom og forklaring. Det finnes ingen spesifikk behandling
  1. Hanno PM, Erickson D, Moldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015; 193: 1545-53. pmid:25623737 PubMed  
  2. EAU European Association of Urology. Guidelines. Chronic Pelvic Pain. Siden besøkt 25.07.2018 uroweb.org  
  3. Hanno PM et al. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999; 161: 553. PubMed  
  4. Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/ interstitial cystitis. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006113. DOI: 10.1002/14651858.CD006113.pub2. The Cochrane Library  
  5. Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173:98-102. PMID: 15592041 PubMed  
  6. Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161:549-552. PMID: 9915446 PubMed  
  7. van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60-67. PMID: 17900797 PubMed  
  8. Sant GR. Etiology, pathogenesis, and diagnosis of interstitial cystitis. Rev Urol 2002; 4 (suppl 1): S9-S15.
  9. Bullones Rodríguez MÁ, Afari N, Buchwald DS; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2013; 189 (suppl 1):S66-S74. PMID: 23234637 PubMed  
  10. Evans RJ, Sant GR. Current diagnosis of interstitial cystitis: an evolving paradigm. Urology 2007; 69(4 suppl): 64-72.
  11. Imamura M, Scott NW, Wallace SA et al. Interventions for treating people with symptoms of bladder pain syndrome: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 7. Art. No.: CD013325. DOI: 10.1002/14651858.CD013325.pub2. DOI  
  12. Peters KM, Tennyson L. Interstitial cystitis (bladder pain syndrome). BMJ Best Practice. Last reviewed: August 2020. bestpractice.bmj.com  
  13. Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT. Rational approaches to the treatment of patients with interstitial cystitis. Urology 2007; 69(4 suppl): 73-81.
  14. Jamison J, Dawson TE, Helfand M. Medical treatments for painful bladder syndrome (interstitial cystitis) (Protocol). Cochrane Database of Systematic Reviews 2007; Issue 3: CD006730. Cochrane (DOI)  
  15. Clemens JQ. Management of interstitial cystitis/bladder pain syndrome. UpToDate, last updated Jul 24, 2020. UpToDate  
  16. Marinkovic SP, Moldwin R, Gillen LM, Stanton SL. The management of interstitial cystitis or painful bladder syndrome in women. Clinical review. BMJ 2009; 339: b2707. BMJ (DOI)  
  17. Foster HE Jr, Hanno PM, Nickel JC, et al. Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol 2010; 183:1853. PubMed  
  18. van Ophoven A, Vonde K, Koch W, et al. Efficacy of pentosan polysulfate for the treatment of interstitial cystitis/bladder pain syndrome: results of a systematic review of randomized controlled trials. Curr Med Res Opin 2019; 35:1495. PubMed  
  19. Nickel JC, Herschorn S, Whitmore KE, et al. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193(3):857-862. doi:10.1016/j.juro.2014.09.036 DOI  
  20. Mayer R, Propert KJ, Peters KM, et al. Interstitial Cystitis Clinical Trials Group. A randomized controlled trial of intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. J Urol 2005; 173: 1186-91. PubMed  
  21. Barua JM, Arance I, Angulo JC, et al. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016;27:1137-1147. PMID: 26590137 PubMed  
  22. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database of Systematic Reviews 2011, Issue 12. Art. No.: CD005493. DOI: 10.1002/14651858.CD005493.pub3. The Cochrane Library  
  23. Kuo HC, Jiang YH, Tsai YC, et al. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment: a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016;35:609-614. PMID: 25914337 PubMed  
  24. Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004;171:2138-2141. PMID: 15126772 PubMed  
  25. Olson LE, Dyer JE, Haq A, Ockrim J, Greenwell TJ. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecol J. 2018;29(2):251-257. doi:10.1007/s00192-017-3355-y DOI  
  26. Peters K, Killinger K, Boguslawski BM, et al. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn. 2010;29:1267-127. PMID: 19787710 PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim
  • Ingard Løge, spesialist allmennmedisin, Edda legesenter, 7030 Trondheim

Tidligere fagmedarbeidere

  • Steinar Hunskår, professor i allmennmedisin, Institutt for samfunnsmedisinske fag, Universitetet i Bergen, Bergen